Earlier this year, Johnson & Johnson voluntarily recalled its baby powder after FDA testing found traces of asbestos in a sample purchased online. In October, the pharmaceutical company released a statement claiming that 15 tests of the same sample the FDA examined, completed by third-party agencies, contained no asbestos.
Hours before the first trial concerning the role of drug companies in the opioid epidemic, Teva Pharmaceuticals and three distributors settled for $260 million. Cuyahoga and Summit, two communities in Ohio, accused Teva – the world’s largest manufacturer of generic drugs – and distributors McKesson, Cardinal Health Inc. and AmerisourceBergen of making false, misleading claims that resulted in addiction and at least 400,000 fatalities.
Proper sanitation precautions can prevent disease outbreaks from occurring in nursing homes. Yet, sometimes regular handwashing and patient isolation is not enough. As “7 On Your Side” found after investigating a deadly superbug in a Brooklyn nursing home, certain conditions appear to have no source.
Monsanto first introduced Roundup, a glyphosate-based herbicide, in 1974 as a solution for weed control. The innovative, less-toxic products were geared toward growing commercial crops, but also could be used by the at-home gardener. In the 1990s, the company capitalized on this need by adding a line of crop seeds for corn, soybeans and canola, immune to Roundup’s effects.
Johnson & Johnson introduced Invokana in 2013 as a drug to treat Type 2 Diabetes. Part of the drug class known as SGLT2 inhibitors (sodium glucose co-transporter 2), Invokana decreases blood sugar through the kidneys, causing them to release more urine. The drug may discard as much as 100 grams of excess glucose per day. Canagliflozin is Invokana’s active ingredient.